NeuroOne Corp - NMTC Short-Term Debt to Capital

NMTC (NeuroOne Medical Technologies) - company brandmark

NeuroOne Medical Technologies (NMTC) is developing versatile neurological platforms, which minimizes the risks associated with narrow specialization. The price trend on GURU.Markets, where the indicator stands at 0.03, complements data regarding deep equipment integration into clinics and physician loyalty following FDA certification. The company leads in neurosurgery through the creation of ultra-precise, minimally invasive sensors for analyzing brain activity in Parkinson's disease.

NMTC - NeuroOne Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/30/2026

Analytical breakdowns for NeuroOne Medical Technologies

- stock value and consensus price forecast:
Price Chart NeuroOne Corp|NMTC - Forecast Levels Chart
- issuer market value details:
Market Capitalization NeuroOne|NMTC - Total Enterprise Value
- book capitalization information:
Book Value per Share NeuroOne Medical Technologies|NMTC - Company Net Assets|Market Capitalization to Book Value Ratio n1mtc.com|NMTC - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Capital NeuroOne Medical Technologies|NMTC - Long-Term Debt to Capital|Short-Term Debt to Equity NeuroOne Medical Technologies Corporation|NMTC - Company Debts|Debts to Book Capitalization NeuroOne|NMTC - Long-Term Debt Volume|Company Current Liabilities NeuroOne Medical Technologies|Quick Ratio n1mtc.com
- earnings and market ratios statistics:
NMTC - Company Net Income
General company analysis:NeuroOne Corp
Brand item of NeuroOne Medical Technologies Corporation

For NeuroOne Medical Technologies (NMTC), which maintains niche leadership in the US neurosurgical sector, the current short-term debt-to-equity ratio reflects a balance between operational liquidity and financial stability. This ratio compares obligations maturing within one year to shareholders' equity, allowing investors to assess default risk and the company's attractiveness for a strategic acquisition as it scales electrode production.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital atecspine.com|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity ENOV (Enovis Corp)|Short-Term Debt to Capital IART (Integra)|Short-Term Debt to Capital Coefficient Establishment Labs Inc (ESTA)|BBNX: Short-Term Debt to Equity Ratio|Current Liabilities to Equity IRMD|EMBC: Short-Term Debt to Capital|Current Liabilities to Capital Tandem Diabetes Care Inc (TNDM)|AXGN (Axogen Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SIBN (SI-BONE Medical)|Short-Term Debt to Equity Ratio OFIX (Orthofix Medical Inc.)|BVS (bioventus.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity OrthoPediatrics KIDS|TMCI - Short-Term Debt to Equity Ratio|Strata Critical Medical Corp - Short-Term Debt to Capital|Current Liabilities to Capital Carlsmed Medical|RXST: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio CLPT|STXS (Stereotaxis) - Short-Term Debt to Capital|Neuronetics Inc. (STIM) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SGHT|Short-Term Debt to Equity Ratio orchestrabiomed.com OBIO|Short-Term Debt to Capital ANIK (Anika Therapeutics, Inc.)|Short-Term Debt to Capital inspiremd.com NSPR|ZJYL - Short-Term Debt to Equity|VANI: Short-Term Debt to Equity|XTNT (xtantmedical.com) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO